These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36812382)

  • 1. The Cooperative Re-Engagement Controlled Trial (CoRECT): Durable Viral Suppression Assessment.
    O'Shea J; Fanfair RN; Williams T; Khalil G; Brady KA; DeMaria A; Villanueva M; Randall LM; Jenkins H; Altice FL; Camp N; Lucas C; Buchelli M; Samandari T; Weidle PJ
    J Acquir Immune Defic Syndr; 2023 Jun; 93(2):134-142. PubMed ID: 36812382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cooperative Re-Engagement Controlled trial (CoRECT): A randomised trial to assess a collaborative data to care model to improve HIV care continuum outcomes.
    Fanfair RN; Khalil G; Williams T; Brady K; DeMaria A; Villanueva M; Randall LM; Jenkins H; Altice FL; Camp N; Lucas C; Buchelli M; Samandari T; Weidle PJ
    Lancet Reg Health Am; 2021 Nov; 3():100057. PubMed ID: 36777404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of HIV Care Outcomes among Recently Out-of-Care Individuals in The Massachusetts Cooperative Re-engagement Controlled Trial Cohort.
    Pokhrel D; Lang SG; Elder H; John B; Roosevelt KA; Klevens M; Randall LM; DeMaria A
    AIDS Behav; 2024 Nov; 28(11):3883-3892. PubMed ID: 39172186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and cost-effectiveness of a collaborative data-to-care intervention for HIV treatment and care in the United States.
    Shrestha RK; Fanfair RN; Randall LM; Lucas C; Nichols L; Camp N; Brady KA; Jenkins H; Altice FL; DeMaria A; Villanueva M; Weidle PJ
    J Int AIDS Soc; 2023 Jan; 26(1):e26040. PubMed ID: 36682053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the exploration, preparation, implementation, sustainment (EPIS) framework to assess the cooperative re-engagement controlled trial (CoRECT).
    Elder H; Lang SG; Villanueva M; John B; Roosevelt K; Altice FL; Brady KA; Gibson B; Buchelli M; DeMaria A; Randall LM
    Front Public Health; 2023; 11():1223149. PubMed ID: 38106893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment.
    Paschen-Wolff MM; Campbell ANC; Tross S; Choo TH; Pavlicova M; Braunstein S; Lazar R; Borges C; Castro M; Berg H; Harriman G; Remien RH; Des Jarlais D
    AIDS Behav; 2022 Feb; 26(2):385-396. PubMed ID: 34331177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Controlled Trial of 60 minutes for Health With Rapid Antiretroviral Therapy to Reengage Persons With HIV Who Are Out of Care.
    Martin TCS; Smith LR; Anderson C; Little SJ
    J Acquir Immune Defic Syndr; 2024 Aug; 96(5):486-493. PubMed ID: 38985446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial.
    Mogoba P; Lesosky M; Zerbe A; Falcao J; Mellins CA; Desmond C; Arnaldo C; Kapogiannis B; Myer L; Abrams EJ
    Trials; 2021 Dec; 22(1):956. PubMed ID: 34961567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersectionality-informed analysis of durable viral suppression disparities in people with HIV.
    Rivera AS; Rusie LK; Feinstein MJ; Siddique J; Lloyd-Jones DM; Beach LB
    AIDS; 2023 Jul; 37(8):1285-1296. PubMed ID: 37070543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
    Wohl DA; Golin CE; Knight K; Gould M; Carda-Auten J; Groves JS; Napravnik S; Cole SR; White BL; Fogel C; Rosen DL; Mugavaro MJ; Pence BW; Flynn PM
    J Acquir Immune Defic Syndr; 2017 May; 75(1):81-90. PubMed ID: 28277487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an HIV Care Coordination Program on Durable Viral Suppression.
    Robertson MM; Penrose K; Irvine MK; Robbins RS; Kulkarni S; Braunstein SL; Waldron L; Harriman G; Nash D
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):46-55. PubMed ID: 30299346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
    Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
    Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
    JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early access to antiretroviral therapy versus standard of care among HIV-positive participants in Eswatini in the public health sector: the MaxART stepped-wedge randomized controlled trial.
    Khan S; Spiegelman D; Walsh F; Mazibuko S; Pasipamire M; Chai B; Reis R; Mlambo K; Delva W; Khumalo G; Zwane M; Fleming Y; Mafara E; Hettema A; Lejeune C; Chao A; Bärnighausen T; Okello V
    J Int AIDS Soc; 2020 Sep; 23(9):e25610. PubMed ID: 32949103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
    Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
    JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cluster Randomized Evaluation of a Health Department Data to Care Intervention Designed to Increase Engagement in HIV Care and Antiretroviral Use.
    Dombrowski JC; Hughes JP; Buskin SE; Bennett A; Katz D; Fleming M; Nunez A; Golden MR
    Sex Transm Dis; 2018 Jun; 45(6):361-367. PubMed ID: 29465679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Data-To-Care Strategies to Optimize the HIV Care Continuum in Connecticut: Results From a Randomized Controlled Trial.
    Machavariani E; Miceli J; Altice FL; Fanfair RN; Speers S; Nichols L; Jenkins H; Villanueva M
    J Acquir Immune Defic Syndr; 2024 May; 96(1):40-50. PubMed ID: 38324241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of Durable Viral Suppression (DVS) Among Criminal Justice-involved (CJI) Black Men Living with HIV in Louisiana.
    Brewer R; Issema R; Moore M; Chrestman S; Mukherjee S; Odlum M; Schneider JA
    AIDS Behav; 2019 Nov; 23(11):2980-2991. PubMed ID: 31250229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Financial Incentives and Real-Time Adherence Monitoring to Promote Daily Adherence to HIV Treatment and Viral Suppression Among People Living With HIV: A Pilot Study.
    Bien-Gund CH; Ho JI; Bair EF; Marcus N; Choi RJ; Szep Z; Althoff A; Momplaisir FM; Thirumurthy H
    J Acquir Immune Defic Syndr; 2021 May; 87(1):688-692. PubMed ID: 33470727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.